- Trials with a EudraCT protocol (33)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
33 result(s) found for: Psychological stress.
Displaying page 1 of 2.
EudraCT Number: 2017-000298-35 | Sponsor Protocol Number: NL60593.028.17 | Start Date*: 2017-05-01 |
Sponsor Name:Tilburg University | ||
Full Title: Oxytocin, friendship and dealing with emotions | ||
Medical condition: There are no medical conditions or disease under investigation. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001263-73 | Sponsor Protocol Number: 30-01-2012_1 | Start Date*: 2012-05-25 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: Involvement of corticotrophin-releasing hormone (CRH) and mucosal mast cells in stress-induced changes in intestinal permeability in healthy volunteers. | |||||||||||||
Medical condition: Stress-induced intestinal hyperpermeability | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004177-83 | Sponsor Protocol Number: 37202 | Start Date*: 2011-11-14 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: Boosting the oxytocin system in acute trauma: The effectiveness of intranasal oxytocin treatments and stimulation of social support on preventing trauma related psychopathology | |||||||||||||
Medical condition: Posttraumatic Stress Disorder (PTSD) according to criteria in the DSM-IV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004153-40 | Sponsor Protocol Number: PTF5 | Start Date*: 2016-01-07 | |||||||||||
Sponsor Name:Competence Centre for Transcultural Psychiatry | |||||||||||||
Full Title: TREATMENT OF SLEEP DISTURBANCES IN TRAUMA-AFFECTED REFUGEES – A RANDOMISED CONTROLLED TRIAL | |||||||||||||
Medical condition: Posttraumatic Stress Disorder (PTSD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006228-19 | Sponsor Protocol Number: PTF3 | Start Date*: 2012-03-21 | |||||||||||
Sponsor Name:Psykiatrisk Center Ballerup | |||||||||||||
Full Title: The treatment of traumatized refugees with Setraline versus Venlafaxine - a randomized trial. | |||||||||||||
Medical condition: Post traumatic stress disorder (PTSD) Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006129-17 | Sponsor Protocol Number: 178S11PF | Start Date*: 2012-05-18 |
Sponsor Name:PASCOE Pharmazeutische Präparate GmbH | ||
Full Title: A randomized, double blind, placebo-controlled pilot study on the efficacy of Passiflora incarnata L. in an acute stressful situation | ||
Medical condition: Since only healthy volunteers will be included in this study, there is no medical condition to be examined. The indication for PASCOFLAIR® is nervous restlessness, a subclinical state of stress-sen... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004823-36 | Sponsor Protocol Number: AZ1-2004 | Start Date*: 2005-03-03 |
Sponsor Name:daacro - diagnostic assessment and clinical research organization | ||
Full Title: Effects of Alprazolam and Flupentixol on endocrine, autonomic and psychological parameters in the Trier Social Stress Test (TSST) | ||
Medical condition: 69 healthy male subjects, age 18-45 undergo a laboratory stress test (TSST) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-006814-35 | Sponsor Protocol Number: MoodBugs_Rifaximin | Start Date*: 2022-09-27 |
Sponsor Name:KU Leuven | ||
Full Title: A randomized, triple-blind, placebo-controlled study on the effect of rifaximin on psychobiological functions in healthy men | ||
Medical condition: Experimental study with healthy participants recruited from the general population; no vulnerable individuals or clinical groups will be involved. Our objective is to test whether rifaximin adminis... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000312-36 | Sponsor Protocol Number: PTSD-FMS | Start Date*: 2021-05-19 | ||||||||||||||||
Sponsor Name:Henri Laborit Hospital | ||||||||||||||||||
Full Title: Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome | ||||||||||||||||||
Medical condition: Post-Traumatic Stress Disorder and fibromyalgia syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002358-22 | Sponsor Protocol Number: C1201 | Start Date*: 2012-08-06 | |||||||||||
Sponsor Name:Biologische Heilmittel Heel GmbH | |||||||||||||
Full Title: NEUPRO DB, efficacy profile of Neurexan in an experimental acute stress setting – an explorative double blind study in healthy probands | |||||||||||||
Medical condition: Neurexan to be effective in fostering mental balance by reducing tension and nervousness during acute stress setting in healthy probands | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002359-40 | Sponsor Protocol Number: C1202 | Start Date*: 2012-07-18 | |||||||||||
Sponsor Name:Biologische Heilmittel Heel GmbH | |||||||||||||
Full Title: NEUPRO OL, Efficacy profile of Neurexan® in an experimental acute stress setting – an explorative open-label study in healthy probands | |||||||||||||
Medical condition: Neurexan to be effective in fostering mental balance by reducing tension and nervousness during acute stress setting in healthy probands | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004629-18 | Sponsor Protocol Number: helmich-veni-2019 | Start Date*: 2017-04-13 |
Sponsor Name:Radboud University Nijmegen | ||
Full Title: The noradrenergic basis of Parkinson’s tremor: a systems-level fMRI approach | ||
Medical condition: Tremor in Parkinson's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-017806-36 | Sponsor Protocol Number: CRC287 | Start Date*: 2010-11-03 | |||||||||||
Sponsor Name:University of Surrey | |||||||||||||
Full Title: Effect of Vitano® on physiological and psychological responses to psychological stress assessed under laboratory conditions and in everyday life. | |||||||||||||
Medical condition: Psychological stress | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005717-36 | Sponsor Protocol Number: 1645-CI-057 | Start Date*: 2012-06-14 |
Sponsor Name:Instituto de Investigación Sanitaria La Fe | ||
Full Title: Extremely low gestational age neonates randomly an assigned to be blindly resuscitated with 21% vs. 60% oxygen: influence upon mortality and chronic conditions in the neonatal period. | ||
Medical condition: Preterm infants aged 30 weeks or less, who need resuscitation / stabilization maneuvers with positive pressure ventilation immediately after birth | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002196-35 | Sponsor Protocol Number: 73520 | Start Date*: 2020-11-16 |
Sponsor Name:Amsterdam UMC, location VUmc | ||
Full Title: post-trial access cohort BUmetanide for Developmental DIsorders | ||
Medical condition: Neurodevelopmental disorders Autism spectrum disorder Attention deficit hyperactivity disorder (ADHD) Learning disorders | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003191-39 | Sponsor Protocol Number: | Start Date*: 2013-01-21 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: The effect of a single-dose of d-cycloserine on the basic effects of cognitive-behaviour therapy for panic disorder - a randomized placebo-controlled trial | |||||||||||||
Medical condition: DSM-IV Panic disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003331-10 | Sponsor Protocol Number: HC03 | Start Date*: 2017-10-16 |
Sponsor Name:Leiden University | ||
Full Title: Acute effects of 40 mg cortisol on emotion and cognition. | ||
Medical condition: None. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-018064-95 | Sponsor Protocol Number: S52151 | Start Date*: 2012-06-18 |
Sponsor Name:University of Leuven | ||
Full Title: Amyloid imaging in late life depression | ||
Medical condition: Late life depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002642-35 | Sponsor Protocol Number: SHR-5/S 04 | Start Date*: 2006-03-08 |
Sponsor Name:Green Medicine AB | ||
Full Title: A randomized double-blind placebo-controlled parallel group study of SHR -5 extract of Rhodiola Rosea as adjuvant therapy in patients with stress related fatigue. | ||
Medical condition: Burnout syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002976-14 | Sponsor Protocol Number: CRI103143 | Start Date*: 2006-09-27 |
Sponsor Name:GlaxoSmithKline Research and Development Limited | ||
Full Title: A phase IIa, single-centre, randomised, placebo-controlled, double-blind, three-period crossover exploratory study investigating the effects on gut autonomic responses of single administrations of ... | ||
Medical condition: Irritable Bowel Syndrome (IBS) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
